Irland - Englisch - HPRA (Health Products Regulatory Authority)

merial animal health limited - live attenuated coronavirus, cr88121 strain - tablets effervescent - 4.0 % - avian infectious bronchitis virus vaccine - fowl - chicken - immunological - live vaccine

Irland - Englisch - HPRA (Health Products Regulatory Authority)

merial animal health limited - live attenuated coronavirus, cr88121 strain - effervescent tablet - 4.0-5.3 log 10 50% embryo infective dose - avian infectious bronchitis virus - chickens - immunological - live vaccine

Saudi-Arabien - Englisch - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

infectious bronchitis coronavirus- strain cr88121 - lyophilisate for suspension - each dose of the reconstituted vaccine contains “104.0-105.3 eid50” eid50

Saudi-Arabien - Englisch - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

infectious bronchitis coronavirus- strain cr88121 - lyophilisate for suspension - each dose of the reconstituted vaccine contains “104.0-105.3 eid50” eid50

Irland - Englisch - HPRA (Health Products Regulatory Authority)

ceva santé animale - live attenuated infectious bronchitis (ib) virus, strain 1/96, variant subtype - lyophilisate for suspension - min. 2.8 per cent - avian infectious bronchitis virus vaccine - fowl - chicken - immunological - live vaccine

Europäische Union - Englisch - EMA (European Medicines Agency)

intervet international bv - live attenuated avian infectious bronchitis virus variant strain 4-91 - immunologicals for aves - chicken - active immunisation of chickens to reduce the respiratory signs of infectious bronchitis caused by the variant strain ib 4-91.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

ceva santé animale - live attenuated infectious bronchitis (ib) virus, strain 1/96, variant subtype - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Irland - Englisch - HPRA (Health Products Regulatory Authority)

ceva-phylaxia veterinary biologicals co. ltd - live attenuated infectious bronchitis disease virus, massachusetts type, strain b48 - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml; isoleucine, quantity: 0.355 mg; leucine, quantity: 0.432 mg - injection, powder for - excipient ingredients: lactose; sorbitol; mannitol; threonine; serine; proline; glycine; alanine; valine; methionine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml; isoleucine, quantity: 0.355 mg - injection, powder for - excipient ingredients: lactose; mannitol; sorbitol; threonine; serine; proline; glycine; alanine; valine; methionine; leucine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.